Futures Rally on Tariff Rollback, Eyeing CPI; Phar…
From Financial Modeling Prep: 2025-05-13 03:09:00
- U.S. stock futures surged following a U.S.-China tariff breakthrough, with Dow Futures up 1.9%, S&P 500 Futures up 2.5%, and Nasdaq 100 Futures up 3.4%. The 90-day tariff truce saw a rotation into equities, especially cyclicals and technology.
- The U.S. slashed tariffs on China from 145% to 30%, while China cut duties on the U.S. from 125% to 10%. The temporary pause on new tariffs during working-level consultations has eased global growth fears.
- Eyes are on April’s Consumer Price Index (CPI) to measure tariff impact on inflation, with economists forecasting a 2.4% year-over-year rise. Stay updated with release timings and estimates using the Economics Calendar API.
- President Trump’s drug-price order aims to reduce U.S. drug prices by 30%-80%, aligning them with global rates. Pharma stocks initially tumbled, with Novo Nordisk down 1% and Eli Lilly flat, but U.S. innovators recovered while European and Asian names showed volatility.
- Watch for detailed tariff implementation timelines and sector carve-outs in U.S.-China discussions, potential CPI surprises impacting equities and bond yields, and legal pushback on the drug-price order creating trading opportunities amid volatility. Stay informed with real-time updates and alerts to navigate pivotal catalysts.
Read more at Financial Modeling Prep:: Futures Rally on Tariff Rollback, Eyeing CPI; Phar…